Skip to content

Jack Seaver

Director at CND Life Sciences.

Earliest Form D on file: May 2025

Director

  • Signed
  • Named
  • Amendment
  • Size is amount sold

Filings

3 filings · 2 offerings
  • Jun 16, 2026

    Debt, named · Form D

    $6.3M

    of $6.3M

    1 amendmentLatest Aug 3, 2026
  • May 6, 2025Amendment

    Equity, named · Form D

    $8.6M

    of $9M

Network

At CND Life Sciences

5 people